CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-10 | FOUSE JACQUALYN A Director | Sale 10b5-1 | −7,497 | $25.90 | $194K | 149,220 |
| 2025-04-08 | FOUSE JACQUALYN A Director | Option exercise 10b5-1 | +15,933 | 156,717 | ||
| 2025-04-08 | FOUSE JACQUALYN A Director | Option exercise · Restricted stock units 10b5-1 | −15,933 | 0 | ||
| 2025-03-05 | Viswanadhan Krishnan Chief Corp Dev & Strategy | Grant or award · Restricted stock units | +24,300 | 24,300 | ||
| 2025-03-05 | Viswanadhan Krishnan Chief Corp Dev & Strategy | Grant or award · Stock options (right to buy) | +55,374 | 55,374 | ||
| 2025-03-03 | Burns James William Chief Legal Officer | Sale 10b5-1 | −1,137 | $35.54 | $40K | 18,650 |
| 2025-03-03 | Burns James William Chief Legal Officer | Sale 10b5-1 | −1,187 | $35.54 | $42K | 21,463 |
| 2025-03-03 | Burns James William Chief Legal Officer | Sale 10b5-1 | −1,681 | $35.54 | $60K | 25,449 |
| 2025-03-03 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −594 | $35.54 | $21K | 21,843 |
| 2025-03-03 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −1,681 | $35.54 | $60K | 25,829 |
| 2025-03-03 | Milanova Tsveta Chief Commercial Officer | Sale 10b5-1 | −1,681 | $35.54 | $60K | 22,892 |
| 2025-03-03 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −4,153 | $35.54 | $148K | 83,139 |
| 2025-03-03 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −8,794 | $35.54 | $313K | 92,345 |
| 2025-03-03 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,137 | $35.54 | $40K | 47,098 |
| 2025-03-03 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,187 | $35.54 | $42K | 49,911 |
| 2025-03-03 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,681 | $35.54 | $60K | 53,897 |
| 2025-03-03 | Washburn Theodore James Jr. Principal Accounting Officer | Sale 10b5-1 | −231 | $35.54 | $8K | 6,038 |
| 2025-03-03 | Washburn Theodore James Jr. Principal Accounting Officer | Sale 10b5-1 | −697 | $35.54 | $25K | 7,691 |
| 2025-03-03 | Washburn Theodore James Jr. Principal Accounting Officer | Sale 10b5-1 | −727 | $35.54 | $26K | 9,414 |
| 2025-03-03 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise · Restricted stock units 10b5-1 | −2,450 | 4,900 |
Page 15 of 48 · 941 trades